Low-fat meal

OTHER3 trials

Sponsors

Hospital Universitari Vall d'Hebron Research Institute, University of Chicago, Eli Lilly and Company

Conditions

HealthyProstate AdenocarcinomaProstate CancerProstate Cancer MetastaticProstate Neoplasm

Phase 1

Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

TerminatedNCT05276492

University of ChicagoProstate Adenocarcinoma, Prostate Cancer, Prostate Cancer Metastatic +1

Start: 2023-01-24End: 2024-11-16Updated: 2025-10-03

A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants

RecruitingNCT07662798

Eli Lilly and CompanyHealthy

Start: 2026-07-01End: 2026-09-01Target: 60Updated: 2026-07-16

Unknown Phase

Effect of Meal Composition on the Responses to Meal Ingestion

CompletedNCT03084276

Hospital Universitari Vall d'Hebron Research InstituteHealthy

Start: 2017-01-16End: 2017-03-21Updated: 2017-04-25